nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—epilepsy syndrome	0.134	1	CbGaD
Levofloxacin—SLC22A6—Acetazolamide—epilepsy syndrome	0.0318	0.0641	CbGbCtD
Levofloxacin—ABCB1—Levetiracetam—epilepsy syndrome	0.0308	0.0622	CbGbCtD
Levofloxacin—SLC22A6—Valproic Acid—epilepsy syndrome	0.0238	0.0479	CbGbCtD
Levofloxacin—ABCB1—Clobazam—epilepsy syndrome	0.0214	0.0431	CbGbCtD
Levofloxacin—ABCB1—Lamotrigine—epilepsy syndrome	0.0206	0.0415	CbGbCtD
Levofloxacin—CYP1A2—Carbamazepine—epilepsy syndrome	0.0203	0.0409	CbGbCtD
Levofloxacin—CYP1A2—Primidone—epilepsy syndrome	0.0189	0.0382	CbGbCtD
Levofloxacin—ABCB1—Carbamazepine—epilepsy syndrome	0.0177	0.0357	CbGbCtD
Levofloxacin—CYP1A2—Propofol—epilepsy syndrome	0.0169	0.0342	CbGbCtD
Levofloxacin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0169	0.0341	CbGbCtD
Levofloxacin—CYP1A2—Phenobarbital—epilepsy syndrome	0.0162	0.0327	CbGbCtD
Levofloxacin—ABCB1—Phenytoin—epilepsy syndrome	0.0159	0.0321	CbGbCtD
Levofloxacin—CYP3A4—Trimethadione—epilepsy syndrome	0.0157	0.0317	CbGbCtD
Levofloxacin—CYP3A4—Felbamate—epilepsy syndrome	0.0157	0.0317	CbGbCtD
Levofloxacin—CYP1A2—Diazepam—epilepsy syndrome	0.0154	0.031	CbGbCtD
Levofloxacin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0148	0.0298	CbGbCtD
Levofloxacin—ABCB1—Phenobarbital—epilepsy syndrome	0.0142	0.0286	CbGbCtD
Levofloxacin—ABCB1—Midazolam—epilepsy syndrome	0.014	0.0282	CbGbCtD
Levofloxacin—ABCB1—Diazepam—epilepsy syndrome	0.0134	0.0271	CbGbCtD
Levofloxacin—CYP3A4—Clonazepam—epilepsy syndrome	0.0134	0.027	CbGbCtD
Levofloxacin—CYP3A4—Clobazam—epilepsy syndrome	0.0128	0.0258	CbGbCtD
Levofloxacin—CYP1A2—Valproic Acid—epilepsy syndrome	0.0121	0.0244	CbGbCtD
Levofloxacin—CYP3A4—Rufinamide—epilepsy syndrome	0.0109	0.022	CbGbCtD
Levofloxacin—CYP3A4—Carbamazepine—epilepsy syndrome	0.0106	0.0214	CbGbCtD
Levofloxacin—CYP3A4—Primidone—epilepsy syndrome	0.00991	0.02	CbGbCtD
Levofloxacin—CYP3A4—Phenytoin—epilepsy syndrome	0.00952	0.0192	CbGbCtD
Levofloxacin—CYP3A4—Propofol—epilepsy syndrome	0.00888	0.0179	CbGbCtD
Levofloxacin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00849	0.0171	CbGbCtD
Levofloxacin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00849	0.0171	CbGbCtD
Levofloxacin—CYP3A4—Midazolam—epilepsy syndrome	0.00837	0.0169	CbGbCtD
Levofloxacin—CYP3A4—Diazepam—epilepsy syndrome	0.00804	0.0162	CbGbCtD
Levofloxacin—CYP3A4—Zonisamide—epilepsy syndrome	0.00785	0.0158	CbGbCtD
Levofloxacin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00634	0.0128	CbGbCtD
Levofloxacin—CYP3A4—Topiramate—epilepsy syndrome	0.00572	0.0115	CbGbCtD
Levofloxacin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00231	0.768	CbGdCrCtD
Levofloxacin—Sparfloxacin—ABCC2—epilepsy syndrome	0.00058	0.268	CrCbGaD
Levofloxacin—Lomefloxacin—ABCC2—epilepsy syndrome	0.000477	0.22	CrCbGaD
Levofloxacin—Ofloxacin—ABCC2—epilepsy syndrome	0.000408	0.188	CrCbGaD
Levofloxacin—Gatifloxacin—ALB—epilepsy syndrome	0.000343	0.158	CrCbGaD
Levofloxacin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000305	0.101	CbGdCrCtD
Levofloxacin—Sparfloxacin—ABCB1—epilepsy syndrome	0.000213	0.0985	CrCbGaD
Levofloxacin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000212	0.0703	CbGdCrCtD
Levofloxacin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000181	0.0602	CbGdCrCtD
Levofloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000145	0.0669	CrCbGaD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.8e-05	9.2e-05	CcSEcCtD
Levofloxacin—Hypotension—Valproic Acid—epilepsy syndrome	2.8e-05	9.18e-05	CcSEcCtD
Levofloxacin—Asthenia—Carbamazepine—epilepsy syndrome	2.8e-05	9.17e-05	CcSEcCtD
Levofloxacin—Agitation—Gabapentin—epilepsy syndrome	2.79e-05	9.17e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	2.79e-05	9.17e-05	CcSEcCtD
Levofloxacin—Discomfort—Pregabalin—epilepsy syndrome	2.79e-05	9.15e-05	CcSEcCtD
Levofloxacin—Nausea—Fosphenytoin—epilepsy syndrome	2.79e-05	9.14e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.78e-05	9.12e-05	CcSEcCtD
Levofloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	2.78e-05	9.12e-05	CcSEcCtD
Levofloxacin—Angioedema—Gabapentin—epilepsy syndrome	2.78e-05	9.11e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.77e-05	9.11e-05	CcSEcCtD
Levofloxacin—Vomiting—Felbamate—epilepsy syndrome	2.77e-05	9.09e-05	CcSEcCtD
Levofloxacin—Dry mouth—Pregabalin—epilepsy syndrome	2.76e-05	9.06e-05	CcSEcCtD
Levofloxacin—Pruritus—Carbamazepine—epilepsy syndrome	2.76e-05	9.05e-05	CcSEcCtD
Levofloxacin—Rash—Felbamate—epilepsy syndrome	2.75e-05	9.01e-05	CcSEcCtD
Levofloxacin—Eye disorder—Topiramate—epilepsy syndrome	2.74e-05	9.01e-05	CcSEcCtD
Levofloxacin—Dermatitis—Felbamate—epilepsy syndrome	2.74e-05	9.01e-05	CcSEcCtD
Levofloxacin—Malaise—Gabapentin—epilepsy syndrome	2.74e-05	9e-05	CcSEcCtD
Levofloxacin—Tinnitus—Topiramate—epilepsy syndrome	2.74e-05	8.99e-05	CcSEcCtD
Levofloxacin—Vertigo—Gabapentin—epilepsy syndrome	2.73e-05	8.96e-05	CcSEcCtD
Levofloxacin—Headache—Felbamate—epilepsy syndrome	2.73e-05	8.96e-05	CcSEcCtD
Levofloxacin—Confusional state—Pregabalin—epilepsy syndrome	2.73e-05	8.95e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.73e-05	8.95e-05	CcSEcCtD
Levofloxacin—Cardiac disorder—Topiramate—epilepsy syndrome	2.73e-05	8.95e-05	CcSEcCtD
Levofloxacin—Flushing—Topiramate—epilepsy syndrome	2.73e-05	8.95e-05	CcSEcCtD
Levofloxacin—Syncope—Gabapentin—epilepsy syndrome	2.73e-05	8.95e-05	CcSEcCtD
Levofloxacin—Leukopenia—Gabapentin—epilepsy syndrome	2.72e-05	8.93e-05	CcSEcCtD
Levofloxacin—Dizziness—Clonazepam—epilepsy syndrome	2.72e-05	8.92e-05	CcSEcCtD
Levofloxacin—Nausea—Vigabatrin—epilepsy syndrome	2.72e-05	8.91e-05	CcSEcCtD
Levofloxacin—Vomiting—Zonisamide—epilepsy syndrome	2.71e-05	8.9e-05	CcSEcCtD
Levofloxacin—Insomnia—Valproic Acid—epilepsy syndrome	2.71e-05	8.88e-05	CcSEcCtD
Levofloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.7e-05	8.88e-05	CcSEcCtD
Levofloxacin—Oedema—Pregabalin—epilepsy syndrome	2.7e-05	8.88e-05	CcSEcCtD
Levofloxacin—Asthenia—Lamotrigine—epilepsy syndrome	2.7e-05	8.87e-05	CcSEcCtD
Levofloxacin—Dizziness—Phenytoin—epilepsy syndrome	2.7e-05	8.86e-05	CcSEcCtD
Levofloxacin—Rash—Zonisamide—epilepsy syndrome	2.69e-05	8.82e-05	CcSEcCtD
Levofloxacin—Infection—Pregabalin—epilepsy syndrome	2.69e-05	8.82e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.69e-05	8.82e-05	CcSEcCtD
Levofloxacin—Palpitations—Gabapentin—epilepsy syndrome	2.69e-05	8.82e-05	CcSEcCtD
Levofloxacin—Dermatitis—Zonisamide—epilepsy syndrome	2.69e-05	8.82e-05	CcSEcCtD
Levofloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.68e-05	8.81e-05	CcSEcCtD
Levofloxacin—Nausea—Diazepam—epilepsy syndrome	2.67e-05	8.77e-05	CcSEcCtD
Levofloxacin—Loss of consciousness—Gabapentin—epilepsy syndrome	2.67e-05	8.77e-05	CcSEcCtD
Levofloxacin—Headache—Zonisamide—epilepsy syndrome	2.67e-05	8.77e-05	CcSEcCtD
Levofloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	2.67e-05	8.76e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.67e-05	8.75e-05	CcSEcCtD
Levofloxacin—Angiopathy—Topiramate—epilepsy syndrome	2.66e-05	8.75e-05	CcSEcCtD
Levofloxacin—Pruritus—Lamotrigine—epilepsy syndrome	2.66e-05	8.74e-05	CcSEcCtD
Levofloxacin—Shock—Pregabalin—epilepsy syndrome	2.66e-05	8.73e-05	CcSEcCtD
Levofloxacin—Somnolence—Valproic Acid—epilepsy syndrome	2.66e-05	8.73e-05	CcSEcCtD
Levofloxacin—Immune system disorder—Topiramate—epilepsy syndrome	2.65e-05	8.71e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Pregabalin—epilepsy syndrome	2.65e-05	8.71e-05	CcSEcCtD
Levofloxacin—Cough—Gabapentin—epilepsy syndrome	2.65e-05	8.7e-05	CcSEcCtD
Levofloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.65e-05	8.69e-05	CcSEcCtD
Levofloxacin—Mediastinal disorder—Topiramate—epilepsy syndrome	2.65e-05	8.69e-05	CcSEcCtD
Levofloxacin—Tachycardia—Pregabalin—epilepsy syndrome	2.64e-05	8.66e-05	CcSEcCtD
Levofloxacin—Chills—Topiramate—epilepsy syndrome	2.64e-05	8.65e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.63e-05	8.64e-05	CcSEcCtD
Levofloxacin—Skin disorder—Pregabalin—epilepsy syndrome	2.63e-05	8.62e-05	CcSEcCtD
Levofloxacin—Hypertension—Gabapentin—epilepsy syndrome	2.62e-05	8.61e-05	CcSEcCtD
Levofloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.61e-05	8.58e-05	CcSEcCtD
Levofloxacin—Vomiting—Clonazepam—epilepsy syndrome	2.61e-05	8.57e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.6e-05	8.54e-05	CcSEcCtD
Levofloxacin—Alopecia—Topiramate—epilepsy syndrome	2.6e-05	8.52e-05	CcSEcCtD
Levofloxacin—Vomiting—Phenytoin—epilepsy syndrome	2.6e-05	8.52e-05	CcSEcCtD
Levofloxacin—Rash—Clonazepam—epilepsy syndrome	2.59e-05	8.5e-05	CcSEcCtD
Levofloxacin—Dermatitis—Clonazepam—epilepsy syndrome	2.59e-05	8.5e-05	CcSEcCtD
Levofloxacin—Chest pain—Gabapentin—epilepsy syndrome	2.59e-05	8.49e-05	CcSEcCtD
Levofloxacin—Myalgia—Gabapentin—epilepsy syndrome	2.59e-05	8.49e-05	CcSEcCtD
Levofloxacin—Arthralgia—Gabapentin—epilepsy syndrome	2.59e-05	8.49e-05	CcSEcCtD
Levofloxacin—Nausea—Felbamate—epilepsy syndrome	2.59e-05	8.49e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.58e-05	8.48e-05	CcSEcCtD
Levofloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.58e-05	8.47e-05	CcSEcCtD
Levofloxacin—Fatigue—Valproic Acid—epilepsy syndrome	2.58e-05	8.47e-05	CcSEcCtD
Levofloxacin—Anxiety—Gabapentin—epilepsy syndrome	2.58e-05	8.46e-05	CcSEcCtD
Levofloxacin—Anorexia—Pregabalin—epilepsy syndrome	2.58e-05	8.46e-05	CcSEcCtD
Levofloxacin—Dizziness—Carbamazepine—epilepsy syndrome	2.58e-05	8.46e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.58e-05	8.46e-05	CcSEcCtD
Levofloxacin—Headache—Clonazepam—epilepsy syndrome	2.57e-05	8.45e-05	CcSEcCtD
Levofloxacin—Rash—Phenytoin—epilepsy syndrome	2.57e-05	8.45e-05	CcSEcCtD
Levofloxacin—Mental disorder—Topiramate—epilepsy syndrome	2.57e-05	8.45e-05	CcSEcCtD
Levofloxacin—Dermatitis—Phenytoin—epilepsy syndrome	2.57e-05	8.44e-05	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.57e-05	8.43e-05	CcSEcCtD
Levofloxacin—Rash—Oxcarbazepine—epilepsy syndrome	2.56e-05	8.4e-05	CcSEcCtD
Levofloxacin—Constipation—Valproic Acid—epilepsy syndrome	2.56e-05	8.4e-05	CcSEcCtD
Levofloxacin—Pain—Valproic Acid—epilepsy syndrome	2.56e-05	8.4e-05	CcSEcCtD
Levofloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.56e-05	8.39e-05	CcSEcCtD
Levofloxacin—Headache—Phenytoin—epilepsy syndrome	2.56e-05	8.39e-05	CcSEcCtD
Levofloxacin—Erythema—Topiramate—epilepsy syndrome	2.56e-05	8.39e-05	CcSEcCtD
Levofloxacin—Malnutrition—Topiramate—epilepsy syndrome	2.56e-05	8.39e-05	CcSEcCtD
Levofloxacin—Discomfort—Gabapentin—epilepsy syndrome	2.56e-05	8.39e-05	CcSEcCtD
Levofloxacin—Headache—Oxcarbazepine—epilepsy syndrome	2.54e-05	8.35e-05	CcSEcCtD
Levofloxacin—Nausea—Zonisamide—epilepsy syndrome	2.53e-05	8.31e-05	CcSEcCtD
Levofloxacin—Dry mouth—Gabapentin—epilepsy syndrome	2.53e-05	8.31e-05	CcSEcCtD
Levofloxacin—Hypotension—Pregabalin—epilepsy syndrome	2.53e-05	8.3e-05	CcSEcCtD
Levofloxacin—Flatulence—Topiramate—epilepsy syndrome	2.52e-05	8.27e-05	CcSEcCtD
Levofloxacin—Tension—Topiramate—epilepsy syndrome	2.51e-05	8.24e-05	CcSEcCtD
Levofloxacin—Dysgeusia—Topiramate—epilepsy syndrome	2.5e-05	8.22e-05	CcSEcCtD
Levofloxacin—Confusional state—Gabapentin—epilepsy syndrome	2.5e-05	8.21e-05	CcSEcCtD
Levofloxacin—Dizziness—Lamotrigine—epilepsy syndrome	2.49e-05	8.17e-05	CcSEcCtD
Levofloxacin—Nervousness—Topiramate—epilepsy syndrome	2.48e-05	8.15e-05	CcSEcCtD
Levofloxacin—Oedema—Gabapentin—epilepsy syndrome	2.48e-05	8.14e-05	CcSEcCtD
Levofloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.48e-05	8.14e-05	CcSEcCtD
Levofloxacin—Vomiting—Carbamazepine—epilepsy syndrome	2.48e-05	8.13e-05	CcSEcCtD
Levofloxacin—Back pain—Topiramate—epilepsy syndrome	2.47e-05	8.12e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.47e-05	8.09e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.46e-05	8.09e-05	CcSEcCtD
Levofloxacin—Infection—Gabapentin—epilepsy syndrome	2.46e-05	8.09e-05	CcSEcCtD
Levofloxacin—Muscle spasms—Topiramate—epilepsy syndrome	2.46e-05	8.07e-05	CcSEcCtD
Levofloxacin—Rash—Carbamazepine—epilepsy syndrome	2.46e-05	8.06e-05	CcSEcCtD
Levofloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	2.45e-05	8.06e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.45e-05	8.03e-05	CcSEcCtD
Levofloxacin—Insomnia—Pregabalin—epilepsy syndrome	2.45e-05	8.03e-05	CcSEcCtD
Levofloxacin—Nausea—Clonazepam—epilepsy syndrome	2.44e-05	8.01e-05	CcSEcCtD
Levofloxacin—Headache—Carbamazepine—epilepsy syndrome	2.44e-05	8.01e-05	CcSEcCtD
Levofloxacin—Shock—Gabapentin—epilepsy syndrome	2.44e-05	8.01e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Gabapentin—epilepsy syndrome	2.43e-05	7.98e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	2.43e-05	7.97e-05	CcSEcCtD
Levofloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.43e-05	7.97e-05	CcSEcCtD
Levofloxacin—Nausea—Phenytoin—epilepsy syndrome	2.42e-05	7.96e-05	CcSEcCtD
Levofloxacin—Tachycardia—Gabapentin—epilepsy syndrome	2.42e-05	7.95e-05	CcSEcCtD
Levofloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	2.41e-05	7.92e-05	CcSEcCtD
Levofloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	2.41e-05	7.92e-05	CcSEcCtD
Levofloxacin—Vision blurred—Topiramate—epilepsy syndrome	2.41e-05	7.91e-05	CcSEcCtD
Levofloxacin—Skin disorder—Gabapentin—epilepsy syndrome	2.41e-05	7.91e-05	CcSEcCtD
Levofloxacin—Somnolence—Pregabalin—epilepsy syndrome	2.4e-05	7.89e-05	CcSEcCtD
Levofloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.4e-05	7.87e-05	CcSEcCtD
Levofloxacin—Tremor—Topiramate—epilepsy syndrome	2.4e-05	7.86e-05	CcSEcCtD
Levofloxacin—Vomiting—Lamotrigine—epilepsy syndrome	2.39e-05	7.86e-05	CcSEcCtD
Levofloxacin—Urticaria—Valproic Acid—epilepsy syndrome	2.38e-05	7.8e-05	CcSEcCtD
Levofloxacin—Rash—Lamotrigine—epilepsy syndrome	2.37e-05	7.79e-05	CcSEcCtD
Levofloxacin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.37e-05	7.79e-05	CcSEcCtD
Levofloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	2.37e-05	7.79e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.37e-05	7.76e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Valproic Acid—epilepsy syndrome	2.37e-05	7.76e-05	CcSEcCtD
Levofloxacin—Anorexia—Gabapentin—epilepsy syndrome	2.36e-05	7.76e-05	CcSEcCtD
Levofloxacin—Anaemia—Topiramate—epilepsy syndrome	2.36e-05	7.76e-05	CcSEcCtD
Levofloxacin—Headache—Lamotrigine—epilepsy syndrome	2.36e-05	7.74e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	2.35e-05	7.72e-05	CcSEcCtD
Levofloxacin—Agitation—Topiramate—epilepsy syndrome	2.35e-05	7.71e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.34e-05	7.66e-05	CcSEcCtD
Levofloxacin—Fatigue—Pregabalin—epilepsy syndrome	2.33e-05	7.65e-05	CcSEcCtD
Levofloxacin—Hypotension—Gabapentin—epilepsy syndrome	2.32e-05	7.61e-05	CcSEcCtD
Levofloxacin—Nausea—Carbamazepine—epilepsy syndrome	2.31e-05	7.6e-05	CcSEcCtD
Levofloxacin—Pain—Pregabalin—epilepsy syndrome	2.31e-05	7.59e-05	CcSEcCtD
Levofloxacin—Constipation—Pregabalin—epilepsy syndrome	2.31e-05	7.59e-05	CcSEcCtD
Levofloxacin—Malaise—Topiramate—epilepsy syndrome	2.31e-05	7.57e-05	CcSEcCtD
Levofloxacin—Vertigo—Topiramate—epilepsy syndrome	2.3e-05	7.54e-05	CcSEcCtD
Levofloxacin—Syncope—Topiramate—epilepsy syndrome	2.29e-05	7.53e-05	CcSEcCtD
Levofloxacin—Leukopenia—Topiramate—epilepsy syndrome	2.29e-05	7.51e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.26e-05	7.42e-05	CcSEcCtD
Levofloxacin—Palpitations—Topiramate—epilepsy syndrome	2.26e-05	7.42e-05	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.25e-05	0.000369	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Topiramate—epilepsy syndrome	2.25e-05	7.38e-05	CcSEcCtD
Levofloxacin—Insomnia—Gabapentin—epilepsy syndrome	2.24e-05	7.36e-05	CcSEcCtD
Levofloxacin—Nausea—Lamotrigine—epilepsy syndrome	2.24e-05	7.34e-05	CcSEcCtD
Levofloxacin—Cough—Topiramate—epilepsy syndrome	2.23e-05	7.32e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.23e-05	7.32e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	2.23e-05	7.31e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ALDH7A1—epilepsy syndrome	2.22e-05	0.000364	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CACNA1A—epilepsy syndrome	2.22e-05	0.000364	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADK—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.22e-05	0.000363	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.21e-05	7.26e-05	CcSEcCtD
Levofloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	2.21e-05	7.26e-05	CcSEcCtD
Levofloxacin—Hypertension—Topiramate—epilepsy syndrome	2.21e-05	7.25e-05	CcSEcCtD
Levofloxacin—Somnolence—Gabapentin—epilepsy syndrome	2.21e-05	7.24e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.2e-05	0.000361	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.2e-05	7.24e-05	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.2e-05	0.000361	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.2e-05	0.00036	CbGpPWpGaD
Levofloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	2.18e-05	7.17e-05	CcSEcCtD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.18e-05	0.000357	CbGpPWpGaD
Levofloxacin—Arthralgia—Topiramate—epilepsy syndrome	2.18e-05	7.14e-05	CcSEcCtD
Levofloxacin—Chest pain—Topiramate—epilepsy syndrome	2.18e-05	7.14e-05	CcSEcCtD
Levofloxacin—Myalgia—Topiramate—epilepsy syndrome	2.18e-05	7.14e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ST3GAL3—epilepsy syndrome	2.18e-05	0.000357	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.17e-05	0.000356	CbGpPWpGaD
Levofloxacin—Anxiety—Topiramate—epilepsy syndrome	2.17e-05	7.12e-05	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.16e-05	7.1e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	2.16e-05	7.08e-05	CcSEcCtD
Levofloxacin—Discomfort—Topiramate—epilepsy syndrome	2.15e-05	7.06e-05	CcSEcCtD
Levofloxacin—Urticaria—Pregabalin—epilepsy syndrome	2.15e-05	7.05e-05	CcSEcCtD
Levofloxacin—Asthenia—Valproic Acid—epilepsy syndrome	2.15e-05	7.05e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.14e-05	7.03e-05	CcSEcCtD
Levofloxacin—Fatigue—Gabapentin—epilepsy syndrome	2.14e-05	7.02e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Pregabalin—epilepsy syndrome	2.14e-05	7.02e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	2.14e-05	7.02e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ADSL—epilepsy syndrome	2.13e-05	0.000349	CbGpPWpGaD
Levofloxacin—Dry mouth—Topiramate—epilepsy syndrome	2.13e-05	6.99e-05	CcSEcCtD
Levofloxacin—Pain—Gabapentin—epilepsy syndrome	2.12e-05	6.96e-05	CcSEcCtD
Levofloxacin—Constipation—Gabapentin—epilepsy syndrome	2.12e-05	6.96e-05	CcSEcCtD
Levofloxacin—Pruritus—Valproic Acid—epilepsy syndrome	2.12e-05	6.95e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.11e-05	0.000346	CbGpPWpGaD
Levofloxacin—Confusional state—Topiramate—epilepsy syndrome	2.1e-05	6.91e-05	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.1e-05	0.000345	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GLUL—epilepsy syndrome	2.09e-05	0.000343	CbGpPWpGaD
Levofloxacin—Oedema—Topiramate—epilepsy syndrome	2.09e-05	6.85e-05	CcSEcCtD
Levofloxacin—Infection—Topiramate—epilepsy syndrome	2.07e-05	6.8e-05	CcSEcCtD
Levofloxacin—Shock—Topiramate—epilepsy syndrome	2.05e-05	6.74e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CACNA1D—epilepsy syndrome	2.05e-05	0.000336	CbGpPWpGaD
Levofloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	2.05e-05	6.72e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Topiramate—epilepsy syndrome	2.05e-05	6.72e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.04e-05	6.71e-05	CcSEcCtD
Levofloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	2.04e-05	6.71e-05	CcSEcCtD
Levofloxacin—Tachycardia—Topiramate—epilepsy syndrome	2.04e-05	6.68e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.03e-05	0.000334	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.03e-05	6.66e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.03e-05	0.000332	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.03e-05	0.000332	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.03e-05	0.000332	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.03e-05	0.000332	CbGpPWpGaD
Levofloxacin—Skin disorder—Topiramate—epilepsy syndrome	2.03e-05	6.65e-05	CcSEcCtD
Levofloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	2.02e-05	6.62e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.99e-05	6.54e-05	CcSEcCtD
Levofloxacin—Anorexia—Topiramate—epilepsy syndrome	1.99e-05	6.53e-05	CcSEcCtD
Levofloxacin—Dizziness—Valproic Acid—epilepsy syndrome	1.98e-05	6.49e-05	CcSEcCtD
Levofloxacin—Urticaria—Gabapentin—epilepsy syndrome	1.97e-05	6.47e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.97e-05	0.000322	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.97e-05	0.000322	CbGpPWpGaD
Levofloxacin—Body temperature increased—Gabapentin—epilepsy syndrome	1.96e-05	6.44e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	1.96e-05	6.44e-05	CcSEcCtD
Levofloxacin—Hypotension—Topiramate—epilepsy syndrome	1.95e-05	6.4e-05	CcSEcCtD
Levofloxacin—Asthenia—Pregabalin—epilepsy syndrome	1.94e-05	6.37e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.94e-05	0.000317	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TXNRD1—epilepsy syndrome	1.92e-05	0.000315	CbGpPWpGaD
Levofloxacin—Pruritus—Pregabalin—epilepsy syndrome	1.91e-05	6.28e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.91e-05	0.000313	CbGpPWpGaD
Levofloxacin—Vomiting—Valproic Acid—epilepsy syndrome	1.9e-05	6.24e-05	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.9e-05	6.24e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.89e-05	0.00031	CbGpPWpGaD
Levofloxacin—Insomnia—Topiramate—epilepsy syndrome	1.89e-05	6.19e-05	CcSEcCtD
Levofloxacin—Rash—Valproic Acid—epilepsy syndrome	1.89e-05	6.19e-05	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.89e-05	0.000309	CbGpPWpGaD
Levofloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	1.88e-05	6.19e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.88e-05	0.000309	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA4—epilepsy syndrome	1.88e-05	0.000309	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.88e-05	0.000309	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.88e-05	0.000308	CbGpPWpGaD
Levofloxacin—Headache—Valproic Acid—epilepsy syndrome	1.87e-05	6.15e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Topiramate—epilepsy syndrome	1.87e-05	6.15e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—AQP1—epilepsy syndrome	1.86e-05	0.000305	CbGpPWpGaD
Levofloxacin—Dyspnoea—Topiramate—epilepsy syndrome	1.86e-05	6.11e-05	CcSEcCtD
Levofloxacin—Somnolence—Topiramate—epilepsy syndrome	1.86e-05	6.09e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	1.85e-05	6.07e-05	CcSEcCtD
Levofloxacin—Dyspepsia—Topiramate—epilepsy syndrome	1.84e-05	6.03e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.83e-05	0.0003	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	1.83e-05	6e-05	CcSEcCtD
Levofloxacin—Decreased appetite—Topiramate—epilepsy syndrome	1.81e-05	5.95e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.8e-05	0.000295	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.8e-05	5.91e-05	CcSEcCtD
Levofloxacin—Fatigue—Topiramate—epilepsy syndrome	1.8e-05	5.91e-05	CcSEcCtD
Levofloxacin—Dizziness—Pregabalin—epilepsy syndrome	1.79e-05	5.87e-05	CcSEcCtD
Levofloxacin—Pain—Topiramate—epilepsy syndrome	1.78e-05	5.86e-05	CcSEcCtD
Levofloxacin—Constipation—Topiramate—epilepsy syndrome	1.78e-05	5.86e-05	CcSEcCtD
Levofloxacin—Asthenia—Gabapentin—epilepsy syndrome	1.78e-05	5.84e-05	CcSEcCtD
Levofloxacin—Nausea—Valproic Acid—epilepsy syndrome	1.78e-05	5.83e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—COX3—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.77e-05	0.00029	CbGpPWpGaD
Levofloxacin—Pruritus—Gabapentin—epilepsy syndrome	1.75e-05	5.76e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.75e-05	0.000287	CbGpPWpGaD
Levofloxacin—Vomiting—Pregabalin—epilepsy syndrome	1.72e-05	5.64e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	1.72e-05	5.64e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.71e-05	5.6e-05	CcSEcCtD
Levofloxacin—Rash—Pregabalin—epilepsy syndrome	1.71e-05	5.6e-05	CcSEcCtD
Levofloxacin—Dermatitis—Pregabalin—epilepsy syndrome	1.7e-05	5.59e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	1.7e-05	5.57e-05	CcSEcCtD
Levofloxacin—Headache—Pregabalin—epilepsy syndrome	1.69e-05	5.56e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.69e-05	0.000277	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	1.68e-05	0.000276	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	1.68e-05	0.000276	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.68e-05	0.000275	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.68e-05	0.000275	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.68e-05	0.000275	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.68e-05	0.000275	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.68e-05	0.000275	CbGpPWpGaD
Levofloxacin—Urticaria—Topiramate—epilepsy syndrome	1.66e-05	5.44e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Topiramate—epilepsy syndrome	1.65e-05	5.41e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Topiramate—epilepsy syndrome	1.65e-05	5.41e-05	CcSEcCtD
Levofloxacin—Dizziness—Gabapentin—epilepsy syndrome	1.64e-05	5.38e-05	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.62e-05	0.000266	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.62e-05	0.000265	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.62e-05	0.000265	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.62e-05	0.000265	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.62e-05	0.000265	CbGpPWpGaD
Levofloxacin—Nausea—Pregabalin—epilepsy syndrome	1.61e-05	5.27e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.6e-05	0.000263	CbGpPWpGaD
Levofloxacin—Vomiting—Gabapentin—epilepsy syndrome	1.58e-05	5.18e-05	CcSEcCtD
Levofloxacin—Rash—Gabapentin—epilepsy syndrome	1.56e-05	5.13e-05	CcSEcCtD
Levofloxacin—Dermatitis—Gabapentin—epilepsy syndrome	1.56e-05	5.13e-05	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.56e-05	0.000256	CbGpPWpGaD
Levofloxacin—Headache—Gabapentin—epilepsy syndrome	1.55e-05	5.1e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	1.54e-05	5.05e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.54e-05	0.000252	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.54e-05	0.000252	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.54e-05	0.000252	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.53e-05	0.00025	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.5e-05	0.000247	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.5e-05	0.000247	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.5e-05	0.000246	CbGpPWpGaD
Levofloxacin—Asthenia—Topiramate—epilepsy syndrome	1.5e-05	4.91e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.48e-05	0.000242	CbGpPWpGaD
Levofloxacin—Pruritus—Topiramate—epilepsy syndrome	1.48e-05	4.85e-05	CcSEcCtD
Levofloxacin—Nausea—Gabapentin—epilepsy syndrome	1.47e-05	4.84e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.45e-05	0.000238	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.43e-05	0.000234	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.43e-05	0.000234	CbGpPWpGaD
Levofloxacin—Diarrhoea—Topiramate—epilepsy syndrome	1.43e-05	4.69e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.41e-05	0.000232	CbGpPWpGaD
Levofloxacin—Dizziness—Topiramate—epilepsy syndrome	1.38e-05	4.53e-05	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.38e-05	0.000226	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	1.37e-05	0.000225	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.37e-05	0.000225	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.37e-05	0.000224	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.34e-05	0.00022	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	1.34e-05	0.000219	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	1.33e-05	0.000218	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.33e-05	0.000218	CbGpPWpGaD
Levofloxacin—Vomiting—Topiramate—epilepsy syndrome	1.33e-05	4.35e-05	CcSEcCtD
Levofloxacin—Rash—Topiramate—epilepsy syndrome	1.32e-05	4.32e-05	CcSEcCtD
Levofloxacin—Dermatitis—Topiramate—epilepsy syndrome	1.31e-05	4.31e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.31e-05	0.000215	CbGpPWpGaD
Levofloxacin—Headache—Topiramate—epilepsy syndrome	1.31e-05	4.29e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.31e-05	0.000214	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.3e-05	0.000214	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.28e-05	0.00021	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.27e-05	0.000209	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.27e-05	0.000209	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.27e-05	0.000208	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.25e-05	0.000205	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.25e-05	0.000205	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.25e-05	0.000205	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.25e-05	0.000205	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.24e-05	0.000204	CbGpPWpGaD
Levofloxacin—Nausea—Topiramate—epilepsy syndrome	1.24e-05	4.07e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.23e-05	0.000201	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.23e-05	0.000201	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.23e-05	0.000201	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.21e-05	0.000199	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.21e-05	0.000199	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	1.2e-05	0.000197	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.19e-05	0.000195	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.18e-05	0.000194	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.16e-05	0.000191	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.16e-05	0.00019	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.16e-05	0.00019	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.16e-05	0.00019	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.14e-05	0.000188	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	1.14e-05	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.14e-05	0.000187	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.14e-05	0.000187	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.14e-05	0.000187	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BCHE—epilepsy syndrome	1.14e-05	0.000187	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.12e-05	0.000184	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.11e-05	0.000183	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.11e-05	0.000183	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.09e-05	0.000179	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	1.09e-05	0.000178	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.09e-05	0.000178	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	1.07e-05	0.000176	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.07e-05	0.000176	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TH—epilepsy syndrome	1.07e-05	0.000175	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.05e-05	0.000172	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.04e-05	0.000171	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.04e-05	0.000171	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.03e-05	0.00017	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.03e-05	0.00017	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.03e-05	0.00017	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.03e-05	0.00017	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.03e-05	0.00017	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.03e-05	0.000169	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.02e-05	0.000167	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.02e-05	0.000167	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.02e-05	0.000167	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	9.7e-06	0.000159	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	9.7e-06	0.000159	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	9.49e-06	0.000156	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.47e-06	0.000155	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.47e-06	0.000155	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.47e-06	0.000155	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	9.3e-06	0.000152	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	9.3e-06	0.000152	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	9.2e-06	0.000151	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	9.2e-06	0.000151	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	9.12e-06	0.000149	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.11e-06	0.000149	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	8.95e-06	0.000147	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	8.93e-06	0.000146	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAT—epilepsy syndrome	8.81e-06	0.000144	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.8e-06	0.000144	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.8e-06	0.000144	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	8.57e-06	0.00014	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	8.37e-06	0.000137	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.27e-06	0.000136	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	8.12e-06	0.000133	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.05e-06	0.000132	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GPX1—epilepsy syndrome	7.97e-06	0.000131	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.84e-06	0.000129	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.84e-06	0.000129	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.8e-06	0.000128	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.5e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.48e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.48e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	7.35e-06	0.00012	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	7.35e-06	0.00012	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.32e-06	0.00012	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.31e-06	0.00012	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.27e-06	0.000119	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.17e-06	0.000118	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.04e-06	0.000115	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AGT—epilepsy syndrome	6.99e-06	0.000115	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.93e-06	0.000114	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.91e-06	0.000113	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APOE—epilepsy syndrome	6.85e-06	0.000112	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.84e-06	0.000112	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.7e-06	0.00011	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.56e-06	0.000108	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.46e-06	0.000106	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.27e-06	0.000103	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.25e-06	0.000103	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.24e-06	0.000102	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.22e-06	0.000102	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	5.99e-06	9.82e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.93e-06	9.72e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—POMC—epilepsy syndrome	5.88e-06	9.64e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.87e-06	9.62e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TH—epilepsy syndrome	5.85e-06	9.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	5.84e-06	9.57e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	5.8e-06	9.51e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.76e-06	9.44e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.67e-06	9.3e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.67e-06	9.3e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ALB—epilepsy syndrome	5.36e-06	8.79e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.25e-06	8.61e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	5.24e-06	8.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.98e-06	8.17e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.96e-06	8.14e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.88e-06	8e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAT—epilepsy syndrome	4.81e-06	7.89e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	4.73e-06	7.76e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	4.69e-06	7.69e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	4.68e-06	7.68e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TH—epilepsy syndrome	4.67e-06	7.65e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.62e-06	7.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.59e-06	7.53e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.51e-06	7.38e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.48e-06	7.34e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.35e-06	7.14e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.04e-06	6.62e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.89e-06	6.38e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.85e-06	6.31e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.84e-06	6.3e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.83e-06	6.28e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AGT—epilepsy syndrome	3.82e-06	6.26e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APOE—epilepsy syndrome	3.74e-06	6.13e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.74e-06	6.13e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.65e-06	5.99e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.61e-06	5.92e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TH—epilepsy syndrome	3.6e-06	5.9e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.48e-06	5.7e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—POMC—epilepsy syndrome	3.21e-06	5.27e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.05e-06	5e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.01e-06	4.93e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.99e-06	4.89e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.97e-06	4.86e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALB—epilepsy syndrome	2.93e-06	4.8e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.89e-06	4.73e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.68e-06	4.4e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.57e-06	4.2e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.56e-06	4.2e-05	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—epilepsy syndrome	2.36e-06	3.86e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.35e-06	3.85e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.34e-06	3.83e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.3e-06	3.78e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.05e-06	3.35e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.98e-06	3.24e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.8e-06	2.96e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.58e-06	2.59e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.29e-06	2.11e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.03e-06	1.69e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.94e-07	1.3e-05	CbGpPWpGaD
